Romina Goldszmid
Investigator
Center for Cancer Research
National Cancer Institute
United States of America
Biography
Dr. Romina Goldszmid received her Ph.D. working on dendritic cell-based vaccines for melanoma immunotherapy from the University of Buenos Aires, Argentina, part of which was performed as a visiting scholar in the laboratory of Dr. Ralph Steinman at the Rockefeller University. She then did her postdoctoral training in infectious disease immunology with Dr. Alan Sher in the Laboratory of Parasitic Diseases (LPD) at the National Institute of Allergy and Infectious Diseases (NIAID), NIH. Dr. Goldszmid then returned to tumor immunology, joining Dr. Giorgio Trinchieri's laboratory in the Cancer and Inflammation Program (CIP) at CCR, NCI, as a Staff Scientist. She is now an NIH Earl Stadtman Investigator in the CIP and an Adjunct Investigator in LPD, NIAID.
Research Interest
mononuclear phagocytes (dendritic cells, macrophages and monocytes), inflammation, tumor immunology, Toxoplasma gondii, microbiota, innate immunity
Publications
-
Goldszmid RS, Trinchieri G. The price of immunity. Nature immunology. 2012 Oct 1;13(10):932-8.
-
Goldszmid RS, Dzutsev A, Trinchieri G. Host immune response to infection and cancer: unexpected commonalities. Cell host & microbe. 2014 Mar 12;15(3):295-305.
-
Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G. Microbiota modulation of myeloid cells in cancer therapy. Cancer immunology research. 2015 Feb 1;3(2):103-9.
